Schroder Investment Management Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Schroder Investment Management Group’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-218,743	Closed	-$2.42M	–	1150
2025 Q3	$2.42M	Sell	218,743 -329,059	-60%	-$3.59M	﹤0.01%	898
2025 Q2	$4.64M	Buy	547,802 +233,017	+74%	+$1.87M	﹤0.01%	779
2025 Q1	$2.61M	Buy	+314,785	New	+$2.55M	﹤0.01%	877
2024 Q3	–	Sell	-997,221	Closed	-$5.69M	–	1204
2024 Q2	$5.69M	Sell	997,221 -43,309	-4%	-$228K	0.01%	756
2024 Q1	$5.21M	Hold	1,040,530	–	–	0.01%	774
2023 Q4	$9.35M	Buy	+1,040,530	New	+$8.57M	0.01%	642

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group's AUPH Position: Q4 2025 in Review

Schroder Investment Management Group sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 218,743 shares — an estimated $2.42M sold.

Schroder Investment Management Group first reported a position in AUPH in Q4 2023 and held it in 6 quarters. The position peaked at $9.35M in Q4 2023. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

Schroder Investment Management Group reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Schroder Investment Management Group sold 218,743 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $2.42M.
Schroder Investment Management Group first reported a position in Aurinia Pharmaceuticals in Q4 2023 and held it in 6 quarters.
Schroder Investment Management Group's Aurinia Pharmaceuticals position peaked at $9.35M in Q4 2023.
255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Schroder Investment Management Group's 13F filing for Q4 2025, filed 13 Feb 2026.